Oncogenomic portals for the visualization and analysis of genome-wide cancer data

Somatically acquired genomic alterations that drive oncogenic cellular processes are of great scientific and clinical interest. Since the initiation of large-scale cancer genomic projects (e.g., the Cancer Genome Project, The Cancer Genome Atlas, and the International Cancer Genome Consortium cancer genome projects), a number of web-based portals have been created to facilitate access to multidimensional oncogenomic data and assist with the interpretation of the data. The portals provide the visualization of small-size mutations, copy number variations, methylation, and gene/protein expression data that can be correlated with the available clinical, epidemiological, and molecular features. Additionally, the portals enable to analyze the gathered data with the use of various user-friendly statistical tools. Herein, we present a highly illustrated review of seven portals, i.e., Tumorscape, UCSC Cancer Genomics Browser, ICGC Data Portal, COSMIC, cBioPortal, IntOGen, and BioProfiling.de. All of the selected portals are user-friendly and can be exploited by scientists from different cancer-associated fields, including those without bioinformatics background. It is expected that the use of the portals will contribute to a better understanding of cancer molecular etiology and will ultimately accelerate the translation of genomic knowledge into clinical practice.

[1]  Kevin B. Jones,et al.  miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells , 2015, Oncotarget.

[2]  M. Stratton,et al.  COSMIC 2005 , 2006, British Journal of Cancer.

[3]  Nuria Lopez-Bigas,et al.  IntOGen: integration and data mining of multidimensional oncogenomic data , 2010, Nature Methods.

[4]  Zhi Chen,et al.  CaSNP: a database for interrogating copy number alterations of cancer genome from SNP array data , 2010, Nucleic Acids Res..

[5]  David Haussler,et al.  Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..

[6]  Gary D Bader,et al.  International network of cancer genome projects , 2010, Nature.

[7]  Xuefei Shi,et al.  The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma , 2015, Oncotarget.

[8]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[9]  P. Fisher,et al.  Analysis of Global Changes in Gene Expression Induced by Human Polynucleotide Phosphorylase (hPNPaseold‐35) , 2014, Journal of cellular physiology.

[10]  K. Gulukota,et al.  Direct observation of genomic heterogeneity through local haplotyping analysis , 2014, BMC Genomics.

[11]  Michael P. Schroeder,et al.  IntOGen-mutations identifies cancer drivers across tumor types , 2013, Nature Methods.

[12]  Modesto Orozco,et al.  Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads , 2014, Nature Biotechnology.

[13]  Curtis R. Pickering,et al.  Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma , 2014, Clinical Cancer Research.

[14]  P. Dessen,et al.  Genome-Wide High-Resolution aCGH Analysis of Gestational Choriocarcinomas , 2012, PloS one.

[15]  Pietro Liò,et al.  The BioMart community portal: an innovative alternative to large, centralized data repositories , 2015, Nucleic Acids Res..

[16]  Chi-Hung Lin,et al.  Single Nucleotide Polymorphisms Associated with Colorectal Cancer Susceptibility and Loss of Heterozygosity in a Taiwanese Population , 2014, PloS one.

[17]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[18]  Martijn A. Huynen,et al.  Predicting Human Genetic Interactions from Cancer Genome Evolution , 2015, PloS one.

[19]  R. Mathur,et al.  Inhibition of Methyltransferases Accelerates Degradation of cFLIP and Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis , 2015, PloS one.

[20]  David Tamborero,et al.  OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..

[21]  M. Morello,et al.  Bioinformatics analysis of the serine and glycine pathway in cancer cells , 2014, Oncotarget.

[22]  W. Hahn,et al.  Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma , 2014, Clinical Cancer Research.

[23]  N. A. Temiz,et al.  APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.

[24]  N. Borcherding,et al.  Bone Marrow Stromal Antigen 2 (BST-2) DNA Is Demethylated in Breast Tumors and Breast Cancer Cells , 2015, PloS one.

[25]  X J Li,et al.  MicroRNA-34a: a potential therapeutic target in human cancer , 2014, Cell Death and Disease.

[26]  Rui Zhang,et al.  An integrated approach to reveal miRNAs’ impacts on the functional consequence of copy number alterations in cancer , 2015, Scientific Reports.

[27]  B. Reva,et al.  MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking , 2014, Clinical Cancer Research.

[28]  D. Dickson.  Wellcome funds cancer database , 1999, Nature.

[29]  Circulating miR-200c and miR-141 and outcomes in patients with breast cancer , 2015, BMC Cancer.

[30]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[31]  C. Croce,et al.  FHIT Suppresses Epithelial-Mesenchymal Transition (EMT) and Metastasis in Lung Cancer through Modulation of MicroRNAs , 2014, PLoS genetics.

[32]  M. Figlerowicz,et al.  High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer , 2015, Oncotarget.

[33]  Michael P. Schroeder,et al.  In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. , 2015, Cancer cell.

[34]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[35]  Mary Goldman,et al.  The UCSC Cancer Genomics Browser: update 2015 , 2014, Nucleic Acids Res..

[36]  A. Antonov,et al.  Characterization of novel markers of senescence and their prognostic potential in cancer , 2014, Cell Death and Disease.

[37]  David Tamborero,et al.  OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action , 2014, Bioinform..

[38]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[39]  Hong Chang,et al.  Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway , 2015, Scientific Reports.

[40]  M. Stratton,et al.  The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website , 2004, British Journal of Cancer.

[41]  D. Haussler,et al.  Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser , 2013, Scientific Reports.

[42]  M. Kahn,et al.  Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma. , 2015, Cancer research.

[43]  Syed Haider,et al.  International Cancer Genome Consortium Data Portal—a one-stop shop for cancer genomics data , 2011, Database J. Biol. Databases Curation.

[44]  Jian Yu,et al.  Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion. , 2014, Carcinogenesis.

[45]  L. Chin,et al.  Making sense of cancer genomic data. , 2011, Genes & development.

[46]  R. Knight,et al.  MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets , 2012, Cell Death and Differentiation.

[47]  Alexey V. Antonov,et al.  BioProfiling.de: analytical web portal for high-throughput cell biology , 2011, Nucleic Acids Res..

[48]  Zihua Zeng,et al.  OLA1 regulates protein synthesis and integrated stress response by inhibiting eIF2 ternary complex formation , 2015, Scientific Reports.

[49]  Marco Beccuti,et al.  The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets , 2015, Nature Communications.

[50]  K. Dahlman-Wright,et al.  Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer. , 2014, Cancer research.

[51]  S. Powers.  Cooperation between MYC and companion 8q genes in hepatocarcinogenesis , 2015, Hepatology.

[52]  Marissa A. LeBlanc,et al.  Germline Mutations in MAP3K6 Are Associated with Familial Gastric Cancer , 2014, PLoS genetics.

[53]  Gary D Bader,et al.  Comprehensive identification of mutational cancer driver genes across 12 tumor types , 2013, Scientific Reports.

[54]  B. Schittek,et al.  Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis , 2014, Molecular Cancer.

[55]  Cheng Liang,et al.  Inferring probabilistic miRNA–mRNA interaction signatures in cancers: a role-switch approach , 2014, Nucleic acids research.

[56]  S A Forbes,et al.  The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.

[57]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[58]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[59]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[60]  Jie Zhang,et al.  Exome sequencing identifies frequent mutation of MLL2 in non–small cell lung carcinoma from Chinese patients , 2014, Scientific Reports.

[61]  Esti Yeger-Lotem,et al.  Cancer Evolution Is Associated with Pervasive Positive Selection on Globally Expressed Genes , 2014, PLoS genetics.

[62]  Ting Wang,et al.  The UCSC Cancer Genomics Browser , 2009, Nature Methods.

[63]  R A Knight,et al.  DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information , 2014, Cell Death and Disease.

[64]  W. Curran,et al.  Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene. , 2014, Cancer research.

[65]  Thomas M. Keane,et al.  POT1 loss-of-function variants predispose to familial melanoma , 2014, Nature Genetics.

[66]  Mary Goldman,et al.  The UCSC Cancer Genomics Browser: update 2015 , 2014, Nucleic Acids Res..

[67]  Michael A. Davies,et al.  Pathways and therapeutic targets in melanoma , 2014, Oncotarget.

[68]  Nuria Lopez-Bigas,et al.  Visualizing multidimensional cancer genomics data , 2013, Genome Medicine.

[69]  A. Gonzalez-Perez,et al.  Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.

[70]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[71]  R A Knight,et al.  PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome , 2014, Oncogene.

[72]  I. Varela,et al.  Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution , 2015, Nature Communications.

[73]  Susan G. Hilsenbeck,et al.  Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of estrogen-receptor positive breast cancers , 2014, Nature Communications.

[74]  A. Morokoff,et al.  Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme , 2015, Oncotarget.

[75]  Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls , 2015, BMC Cancer.

[76]  Yan Guo,et al.  Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk , 2014, Nature Genetics.

[77]  A. Antonov,et al.  DNA damage modulates interactions between microRNAs and the 26S proteasome , 2014, Oncotarget.